In NAFLD, the expression of α1-, β1-, β2-, and β3-AR is dependent on the stage of fibrosis/cirrhosis: while in an early stage of fibrosis, these receptors are decreased, in progressive fibrosis/cirrhosis, they are markedly upregulated [13]. The gene discussed is ADRB3; the disease is Cirrhosis.